Open Actively Recruiting

National Wilm's Tumor Study Late Effects

About

Brief Summary

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Primary Purpose
Screening
Study Type
Interventional
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
85 Years

Inclusion Criteria:

Previously enrolled in NWTS 5.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
10-000010
Category
Kidney Cancer
Location
  • UCLA Westwood
For Providers
NCT No.
NCT00228696
For detailed technical eligibility, visit ClinicalTrials.gov.